Chief Financial Officer
Mon, Apr 1, 2024
Apr 1
exercised or converted securities in APLS
4,000 shares @ $0.00
Decreased holdings by -1.50%
Net across this filing: 0.00% (+0 shares)
Option Exercise
Sale tied to a same-time option exercise
APLSApellis Pharmaceuticals, Inc.
HealthcareBiotechnology